Repeat Dose
Showing 1 - 25 of >10,000
Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)
Active, not recruiting
- Alcohol Use Disorder
- DCR-AUD
- Placebo
-
Glendale, CaliforniaParexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023
Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- Placebo
- (no location specified)
Jan 9, 2023
Atopic Dermatitis Trial in Glendale (UCB1381, Placebo)
Recruiting
- Atopic Dermatitis
- UCB1381
- Placebo
-
Glendale, CaliforniaUp0110 101
Jan 20, 2023
Post Operative Pain, Acute Trial in Vejle (Dexamethasone 24 mg, Placebo)
Recruiting
- Post Operative Pain, Acute
- Dexamethasone 24 mg
- Placebo
-
Vejle, DenmarkVejle Hospital. Orthopedic Surgery Department. Clinical Research
Oct 12, 2022
Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)
Not yet recruiting
- Colitis, Ulcerative
- GSK4381406
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Aug 11, 2023
Acute Kidney Injury, HIE Trial in Oklahoma City (Single Dose Theophylline, Repeat Dose Theophylline, Placebo)
Not yet recruiting
- Acute Kidney Injury
- HIE
- Single Dose Theophylline
- +2 more
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
May 2, 2023
Healthy Trial in Miami (CORT125134 150 mg, CORT125134 250 mg, CORT125134 dose to be determined)
Completed
- Healthy
- CORT125134 150 mg
- +2 more
-
Miami, FloridaQuotient Sciences, Miami, Inc.
Oct 17, 2023
Drug Kinetics, Drug Effects on Physiology Trial in Mount-Royal (sargramostim)
Completed
- Drug Kinetics
- Drug Effects on Physiology
- sargramostim
-
Mount-Royal, Quebec, CanadaAltaSciences
Sep 30, 2022
Lumbosacral Radicular Pain Trial in Boise (SP-102)
Completed
- Lumbosacral Radicular Pain
-
Boise, IdahoSemnur Research Site 1
Jan 5, 2022
Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)
Recruiting
- Metastatic Castration-resistant Prostate Cancer, mCRPC
-
Seoul, Korea, Republic ofThe Catholic University of Korea, Seoul, St, Mary's Hospital, 22
Dec 8, 2022
Acute Repetitive Seizures, Breakthrough Seizures Trial in United States (NRL-1)
Completed
- Acute Repetitive Seizures
- Breakthrough Seizures
-
Little Rock, Arkansas
- +4 more
Jan 27, 2022
Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- [177Lu]Ludotadipep 3.7 GBq
- (no location specified)
Jul 12, 2022
Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3923868, Matching , Monodose RS01)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Sep 26, 2022
Rheumatoid Arthritis Trial in Los Angeles, Tustin, Miami (Low dose ORTD-1, Low dose vehicle control, High dose ORTD-1)
Completed
- Rheumatoid Arthritis
- Low dose ORTD-1
- +3 more
-
Los Angeles, California
- +2 more
Oct 15, 2021
Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- Placebo
- (no location specified)
May 26, 2022
Paroxysmal Atrial Fibrillation (PAF) Trial in Belgium, Netherlands (Flecainide Acetate)
Completed
- Paroxysmal Atrial Fibrillation (PAF)
- Flecainide Acetate
-
Bonheiden, Belgium
- +8 more
Dec 2, 2022
Healthy Trial in London (ETD002 - single dose, Placebo - single dose, ETD002 - 7 day repeat dose)
Completed
- Healthy
- ETD002 - single dose
- +6 more
-
London, United KingdomHammersmith Medicines Research
May 20, 2021